682 585

Cited 0 times in

정신분열병에서 Quetiapine의 치료 효능과 안전성

Other Titles
 Efficacy and Safety of Quetiapine in Patients with Schizophrenia 
Authors
 김찬형 
Citation
 Korean Journal of Psychopharmacology (대한정신약물학회지), Vol.17(s1) : 14-26, 2006 
Journal Title
Korean Journal of Psychopharmacology(대한정신약물학회지)
ISSN
 1017-5717 
Issue Date
2006
Keywords
Atypical antipsychotics ; Efficay ; Safety ; Quetiapine ; Schizophrenia
Abstract
Atypical antipsychotics have an improved tolerability profile, and are less likely to cause debilitating extrapyram-idal symptoms (EPS) than are the conventional antipsychotics. Quetiapine, the fourth atypical antipsychotic, was marketed in Korea as well as in the United States and is also available in over 85 countries worldwide. The aim of this review is to describe the efficacy, safety, and tolerability of quetiapine in treating patients with schizophrenia. Based upon a review of published findings, quetiapine has shown efficacy in a broad symptom range and a good tolerability profile featuring placebo-level EPS and prolactin across the recommended dose range, and a favorable long-term weight profile. In addition, quetiapine has beneficial calming properties and successfully treats the symp-toms of aggression, hostility and anxiety that can accompany acute exacerbations of schizophrenia. In conclusion, quetiapine is well tolerated and clinically effective in the treatment of schizophrenia.
Files in This Item:
T200600503.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Psychiatry (정신과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Chan Hyung(김찬형)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/109362
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links